Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Normalization of Fasting Glucose by Intensified Insulin Therapy on the Incidence of Restenosis After Peripheral Angioplasty in Patients With Type 2 Diabetes.

NCT01150617 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT01150617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01150617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Normalization of Fasting Glucose by Intensified Insulin Therapy on the Incidence of Restenosis After Peripheral Angioplasty in Patients With Type 2 Diabetes.
Lead sponsor
IRCCS San Raffaele
Phase
Phase 4
Overall status
Terminated
Start date
December 31, 2008
Completion date
May 31, 2011
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral vascular disease, type 2 diabetes mellitus